From: Gross, Mary
Sent: Friday, August 09, 2002 12:50 PM
To: Butler, Jennie C
Subject: FW: 26 July FDA Public Meeting-barcoding

Importance: High



-----Original Message-----
From: Laurence.Edzenga@gsk.com [mailto:Laurence.Edzenga@gsk.com]
Sent: Thursday, July 11, 2002 5:10 PM
To: grossm@cder.fda.gov
Cc: Bruce.D.Cohen@gsk.com; Vincent.P.Pisculli@gsk.com;
Luc.Vanden-Houten@gsk.com; Jayne.Gilbert@chiron.com;
james.mundt@usgms02.us.sb.com
Subject: 26 July FDA Public Meeting
Importance: High


Mary,

Please include me as a speaker, at your FDA Bar Code Label Requirements for
Human Drug Products public meeting 26 July, 2002, as the representative for
VISI (Vaccines Identification Standardization Initiative) and the
Vaccine/Biologic products industry.

Also, please schedule my brief presentation right after the PhRMA slot in
the schedule, if any way possible.
My 15 minute presentation coincides with PhRMA, as a co-contributor to the
PhRMA statement, with my presentation adding details specific to
Biologicals.

Laurence Edzenga
VISI Representative
Avantis, Chiron, GlaxoSmithKline, Merck and Wyeth Labs